✦ LIBER ✦

A5.2 Stimulation of humoral systemic and mucosal immunity in patients with inflammations of the oral mucosa and parodont after treatment with a polybacterial immunomodulator

Book ID: 119564017
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 109 KB
Volume: 26
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(05)80219-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Stimulation of Immune Antibodies Ant

The Stimulation of Immune Antibodies Anti-A and Anti-B in Patients after Treatment with Cryoprecipitate and Factor IX Concentrate (P.P.S.B. According to Soulier)

✍ R. L. McShine; V. A. J. M. Kunst 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Combination therapy with rituximab and i

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

✍ Antonio Salar; Eva Domingo-Domenech; Cristina Estany; Miguel A. Canales; Fernand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 3 views

Long-term antibodies after an oral immun

Long-term antibodies after an oral immunization with cholera toxin are synthesized in the bone marrow and may play a role in the regulation of memory B-cell maintenance at systemic and mucosal sites

✍ R. Benedetti; P. Lev; E. Massouh; J. Fló 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 985 KB

TREATMENT OF A PATIENT IN A RELAPSE AFTE

TREATMENT OF A PATIENT IN A RELAPSE AFTER BONE MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH THE SYSTEMIC ADMINISTRATION OF ALLOGENEIC LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2

✍ Toshihisa Komori; Haruo Sugiyama; Hiroyasu Ogawa; Yoshihiro Oka; Seigou Miyake; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

5.44 Consolidation Therapy with Subcutan

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB